Understanding the Mechanism of Action of NAI-112, a Lanthipeptide with Potent Antinociceptive Activity
NAI-112, a glycosylated, labionine-containing lanthipeptide with weak antibacterial activity, has demonstrated analgesic activity in relevant mouse models of nociceptive and neuropathic pain. However, the mechanism(s) through which NAI-112 exerts its analgesic and antibacterial activities is not kno...
Enregistré dans:
Auteurs principaux: | Arianna Tocchetti, Marianna Iorio, Zeeshan Hamid, Andrea Armirotti, Angelo Reggiani, Stefano Donadio |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9f0b0a372125406d8ba46ba0a7a89b68 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
El incremento de los permisos como trabajadores temporales a mexicanos en los Estados Unidos: viejas formas de contratación en el sector agrícola estadounidense
par: Granados Alcantar, José Aurelio, et autres
Publié: (2021) -
Examining the impact of visa restrictions on international tourist flows using panel data: Un análisis con datos de panel
par: Artal-Tur,Andrés, et autres
Publié: (2016) -
Lysophosphatidic Acid Alters The Expression of Apoptosis Related Genes and miR-22 in Cultured and Autotransplanted Ovaries
par: Maryam Dehghan, et autres
Publié: (2021) -
Serum Metabolomics of Tick-Borne Encephalitis Based on Orbitrap-Mass Spectrometry
par: Zhang M, et autres
Publié: (2021) -
An Integrated Metabolomic and Genomic Mining Workflow To Uncover the Biosynthetic Potential of Bacteria
par: Maria Maansson, et autres
Publié: (2016)